Related Experiment Videos
[Normal myelination in childhood brains using MRI--a meta analysis]
M Staudt1, I Krägeloh-Mann, W Grodd
1Sektion experimentelle Kernspinresonanz des ZNS, Radiologische Universitätsklinik, Tübingen. martin.staudt@med.uni-tuebingen.de
Summary
This study establishes age limits for brain myelination assessment using T1-weighted (T1w) and T2-weighted (T2w) MRI. A common timetable for myelination in various brain regions is provided for reliable clinical evaluation.
Area of Science:
- Neuroimaging
- Developmental Neuroscience
- Radiology
Background:
- Myelination is a critical process in brain development.
- Accurate assessment of myelination timing is essential for diagnosing developmental disorders.
- Existing timetables for myelination vary, necessitating a consolidated reference.
Purpose of the Study:
- To establish standardized age limits for assessing normal brain myelination.
- To create a unified timetable for myelination using T1-weighted (T1w) and T2-weighted (T2w) magnetic resonance imaging (MRI).
Main Methods:
- Systematic review and comparison of previous publications on brain myelination.
- Consolidation of data from multiple studies to establish consensus on myelination timelines.
- Analysis of T1w and T2w imaging findings across different age groups.
Main Results:
- A common timetable for brain myelination was established, agreeing with most previous studies.
- Specific age ranges (in months) for myelination in various brain regions (e.g., internal capsule, corpus callosum, cerebral lobes) were detailed for T1w and T2w images.
- Myelination in the medulla oblongata, thalamus, and corona radiata is visible by 1 month of age on both T1w and T2w images.
Conclusions:
- The consolidated age limits provide a more reliable basis for assessing brain myelination compared to single-study timetables.
- This standardized approach aids in the accurate interpretation of brain development in pediatric populations.
- The established timetable is valuable for clinical neuroradiology and research in neurodevelopmental disorders.